BR0009052A - Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica - Google Patents

Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica

Info

Publication number
BR0009052A
BR0009052A BR0009052-2A BR0009052A BR0009052A BR 0009052 A BR0009052 A BR 0009052A BR 0009052 A BR0009052 A BR 0009052A BR 0009052 A BR0009052 A BR 0009052A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
negative bacteria
membrane fraction
gram negative
preparing
Prior art date
Application number
BR0009052-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Christine Libon
Nathalie Corvaia
Alain Beck
Jean-Yves Bonnefoy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR0009052A publication Critical patent/BR0009052A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BR0009052-2A 1999-03-15 2000-03-15 Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica BR0009052A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903154A FR2790960B1 (fr) 1999-03-15 1999-03-15 Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/000623 WO2000054790A1 (fr) 1999-03-15 2000-03-15 Fractions membranaires bacteriennes immunostimulantes dans le traitement de cancers

Publications (1)

Publication Number Publication Date
BR0009052A true BR0009052A (pt) 2001-12-26

Family

ID=9543185

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009052-2A BR0009052A (pt) 1999-03-15 2000-03-15 Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica

Country Status (14)

Country Link
US (1) US7033591B1 (https=)
EP (1) EP1161250B9 (https=)
JP (1) JP2002539170A (https=)
CN (1) CN1202127C (https=)
AT (1) ATE302014T1 (https=)
AU (1) AU776350B2 (https=)
BR (1) BR0009052A (https=)
CA (1) CA2367211A1 (https=)
DE (1) DE60022011T2 (https=)
DK (1) DK1161250T3 (https=)
ES (1) ES2246831T3 (https=)
FR (1) FR2790960B1 (https=)
WO (1) WO2000054790A1 (https=)
ZA (1) ZA200107368B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808445A1 (fr) * 2000-05-04 2001-11-09 Pf Medicament Proteine omp associee a un lysat de cellules tumorales autologues et/ou heterologues
FR2809014A1 (fr) * 2000-05-16 2001-11-23 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie comme agent antimicrobien
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
EP4241853B1 (en) * 2013-11-26 2026-02-11 Zoetis Services LLC Compositions for induction of immune response
GB201713975D0 (en) * 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use
CN113727722A (zh) * 2019-02-22 2021-11-30 伊夫罗生物科学公司 细菌膜制剂
EP4190894A1 (en) 2021-12-03 2023-06-07 CiMaas B.V. Method for the production of mature dendritic cells in vitro using a bacterial lysate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
AU603585B2 (en) * 1986-05-07 1990-11-22 Sloan-Kettering Institute For Cancer Research Vaccine for stimulating or enhancing production of antibodies directed against GM2
AU7477791A (en) * 1990-03-02 1991-09-18 Joaquin J. Jimenez Method for treating cancer using combination chemotherapy and brm
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5776898A (en) * 1991-05-14 1998-07-07 Dana-Farber Cancer Institute Method for treating a tumor with a chemotherapeutic agent
US5830686A (en) * 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
FR2785542B1 (fr) * 1998-11-06 2001-02-09 Pf Medicament UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES

Also Published As

Publication number Publication date
CN1343125A (zh) 2002-04-03
CN1202127C (zh) 2005-05-18
AU3298100A (en) 2000-10-04
EP1161250B1 (fr) 2005-08-17
EP1161250B9 (fr) 2006-07-05
JP2002539170A (ja) 2002-11-19
DE60022011T2 (de) 2006-06-14
FR2790960B1 (fr) 2002-10-31
DE60022011D1 (de) 2005-09-22
US7033591B1 (en) 2006-04-25
ATE302014T1 (de) 2005-09-15
WO2000054790A1 (fr) 2000-09-21
CA2367211A1 (fr) 2000-09-21
FR2790960A1 (fr) 2000-09-22
AU776350B2 (en) 2004-09-02
EP1161250A1 (fr) 2001-12-12
ES2246831T3 (es) 2006-03-01
ZA200107368B (en) 2002-06-26
DK1161250T3 (da) 2005-12-12

Similar Documents

Publication Publication Date Title
MX2025003080A (es) Conjugados de il-15, y sus usos
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
NO20073088L (no) Deacylering av LPS i gramnegative bakterier
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
DE69905170D1 (en) Thiazolopyrimidinderivate
IL146125A0 (en) Novel quinones as disease therapies
AR033574A1 (es) Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
EP4656248A3 (en) Anti-c-met antibody drug conjugates
BR0009052A (pt) Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica
CA2131565A1 (en) Organopolysiloxanes Containing Hydrophilic Groups
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
AU6698000A (en) Bifidobacteria capable of preventing diarrhea
WO2004098529A3 (en) Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
BR0009051A (pt) Utilização de uma fração de membrana de klebsiella pneumoniae associada a um antìgeno ou hapteno, e, composição farmacêutica
ATE530194T1 (de) Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
WO2002057281A3 (en) Aminoglycosides as antibiotics
EP1011329A4 (en) PACLITAXELS 7-METHYLTHIOOXOMETHYLE AND 7-METHYLTHIODIOXOMETHYLE
AU7079300A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.